Literature DB >> 19687324

Second-line chemotherapy for advanced urothelial cancer: because we should or because we can?

Robert Dreicer.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19687324     DOI： 10.1200/JCO.2009.23.8071

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

Review 1.  Neoadjuvant chemotherapy for invasive bladder cancer.

Authors:  Guru Sonpavde; Cora N Sternberg
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

Review 2.  Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma.

Authors:  Metin Kurtoglu; Nicole N Davarpanah; Rui Qin; Thomas Powles; Jonathan E Rosenberg; Andrea B Apolo
Journal:  Clin Genitourin Cancer       Date:  2015-03-05       Impact factor: 2.872

Review 3.  Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder.

Authors:  E El Rassy; T Assi; Z Bakouny; N Pavlidis; J Kattan
Journal:  Clin Transl Oncol       Date:  2018-09-04       Impact factor: 3.405

4.  The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells.

Authors:  Sergey A Dyshlovoy; Ramin Madanchi; Jessica Hauschild; Katharina Otte; Winfried H Alsdorf; Udo Schumacher; Vladimir I Kalinin; Alexandra S Silchenko; Sergey A Avilov; Friedemann Honecker; Valentin A Stonik; Carsten Bokemeyer; Gunhild von Amsberg
Journal:  BMC Cancer       Date:  2017-02-01       Impact factor: 4.430

5.  Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) as second-line therapy for patients with advanced urothelial cancer.

Authors:  Sheng Zhang; Hongxi Xue; Qiang Chen
Journal:  Oncotarget       Date:  2016-09-06

6.  Second-Line Systemic Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials.

Authors:  Hyun Sik Yoon; Cheol Kwak; Hyeon Hoe Kim; Hyung Suk Kim; Ja Hyeon Ku
Journal:  Front Oncol       Date:  2019-07-25       Impact factor: 6.244

7.  Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands.

Authors:  Daan J Reesink; Ewoudt M W van de Garde; Bas J M Peters; Paul B van der Nat; Maartje Los; Simon Horenblas; Harm H E van Melick
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.